Albert Schweitzer Hospital

Reimagining research equity and beneficial community impact: reflections from the GSK Africa Open Lab inaugural cohort

Global health research continues to rely heavily on knowledge generated outside the regions that bear the greatest disease burden, reinforcing structural inequities in scientific leadership and innovation. The GlaxoSmithKline (GSK) Africa Open Lab (AOL) was established to address...

High-Risk Clones of Carbapenem-Resistant Pseudomonas aeruginosa in India: Genome and Traits

Pseudomonas aeruginosa is a notorious opportunistic pathogen constituting a major cause of health care-associated infections worldwide. Intrinsic resistance to multiple antibiotics, with acquired resistance mechanisms and hypervirulence make it a critical target for genomic inves...